Cargando…
Systemic Pharmacological Smoothened Inhibition Reduces Lung T-Cell Infiltration and Ameliorates Th2 Inflammation in a Mouse Model of Allergic Airway Disease
Allergic asthma is a common inflammatory airway disease in which Th2 immune response and inflammation are thought to be triggered by inhalation of environmental allergens. Many studies using mouse models and human tissues and genome-wide association have indicated that Sonic Hedgehog (Shh) and the H...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463265/ https://www.ncbi.nlm.nih.gov/pubmed/34580585 http://dx.doi.org/10.3389/fimmu.2021.737245 |
_version_ | 1784572364705497088 |
---|---|
author | Yánez, Diana C. Papaioannou, Eleftheria Chawda, Mira M. Rowell, Jasmine Ross, Susan Lau, Ching-In Crompton, Tessa |
author_facet | Yánez, Diana C. Papaioannou, Eleftheria Chawda, Mira M. Rowell, Jasmine Ross, Susan Lau, Ching-In Crompton, Tessa |
author_sort | Yánez, Diana C. |
collection | PubMed |
description | Allergic asthma is a common inflammatory airway disease in which Th2 immune response and inflammation are thought to be triggered by inhalation of environmental allergens. Many studies using mouse models and human tissues and genome-wide association have indicated that Sonic Hedgehog (Shh) and the Hedgehog (Hh) signaling pathway are involved in allergic asthma and that Shh is upregulated in the lung on disease induction. We used a papain-induced mouse model of allergic airway inflammation to investigate the impact of systemic pharmacological inhibition of the Hh signal transduction molecule smoothened on allergic airway disease induction and severity. Smoothened-inhibitor treatment reduced the induction of Shh, IL-4, and IL-13 in the lung and decreased serum IgE, as well as the expression of Smo, Il4, Il13, and the mucin gene Muc5ac in lung tissue. Smoothened inhibitor treatment reduced cellular infiltration of eosinophils, mast cells, basophils, and CD4+ T-cells to the lung, and eosinophils and CD4+ T-cells in the bronchoalveolar lavage. In the mediastinal lymph nodes, smoothened inhibitor treatment reduced the number of CD4+ T-cells, and the cell surface expression of Th2 markers ST2 and IL-4rα and expression of Th2 cytokines. Thus, overall pharmacological smoothened inhibition attenuated T-cell infiltration to the lung and Th2 function and reduced disease severity and inflammation in the airway. |
format | Online Article Text |
id | pubmed-8463265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84632652021-09-26 Systemic Pharmacological Smoothened Inhibition Reduces Lung T-Cell Infiltration and Ameliorates Th2 Inflammation in a Mouse Model of Allergic Airway Disease Yánez, Diana C. Papaioannou, Eleftheria Chawda, Mira M. Rowell, Jasmine Ross, Susan Lau, Ching-In Crompton, Tessa Front Immunol Immunology Allergic asthma is a common inflammatory airway disease in which Th2 immune response and inflammation are thought to be triggered by inhalation of environmental allergens. Many studies using mouse models and human tissues and genome-wide association have indicated that Sonic Hedgehog (Shh) and the Hedgehog (Hh) signaling pathway are involved in allergic asthma and that Shh is upregulated in the lung on disease induction. We used a papain-induced mouse model of allergic airway inflammation to investigate the impact of systemic pharmacological inhibition of the Hh signal transduction molecule smoothened on allergic airway disease induction and severity. Smoothened-inhibitor treatment reduced the induction of Shh, IL-4, and IL-13 in the lung and decreased serum IgE, as well as the expression of Smo, Il4, Il13, and the mucin gene Muc5ac in lung tissue. Smoothened inhibitor treatment reduced cellular infiltration of eosinophils, mast cells, basophils, and CD4+ T-cells to the lung, and eosinophils and CD4+ T-cells in the bronchoalveolar lavage. In the mediastinal lymph nodes, smoothened inhibitor treatment reduced the number of CD4+ T-cells, and the cell surface expression of Th2 markers ST2 and IL-4rα and expression of Th2 cytokines. Thus, overall pharmacological smoothened inhibition attenuated T-cell infiltration to the lung and Th2 function and reduced disease severity and inflammation in the airway. Frontiers Media S.A. 2021-09-10 /pmc/articles/PMC8463265/ /pubmed/34580585 http://dx.doi.org/10.3389/fimmu.2021.737245 Text en Copyright © 2021 Yánez, Papaioannou, Chawda, Rowell, Ross, Lau and Crompton https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Yánez, Diana C. Papaioannou, Eleftheria Chawda, Mira M. Rowell, Jasmine Ross, Susan Lau, Ching-In Crompton, Tessa Systemic Pharmacological Smoothened Inhibition Reduces Lung T-Cell Infiltration and Ameliorates Th2 Inflammation in a Mouse Model of Allergic Airway Disease |
title | Systemic Pharmacological Smoothened Inhibition Reduces Lung T-Cell Infiltration and Ameliorates Th2 Inflammation in a Mouse Model of Allergic Airway Disease |
title_full | Systemic Pharmacological Smoothened Inhibition Reduces Lung T-Cell Infiltration and Ameliorates Th2 Inflammation in a Mouse Model of Allergic Airway Disease |
title_fullStr | Systemic Pharmacological Smoothened Inhibition Reduces Lung T-Cell Infiltration and Ameliorates Th2 Inflammation in a Mouse Model of Allergic Airway Disease |
title_full_unstemmed | Systemic Pharmacological Smoothened Inhibition Reduces Lung T-Cell Infiltration and Ameliorates Th2 Inflammation in a Mouse Model of Allergic Airway Disease |
title_short | Systemic Pharmacological Smoothened Inhibition Reduces Lung T-Cell Infiltration and Ameliorates Th2 Inflammation in a Mouse Model of Allergic Airway Disease |
title_sort | systemic pharmacological smoothened inhibition reduces lung t-cell infiltration and ameliorates th2 inflammation in a mouse model of allergic airway disease |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463265/ https://www.ncbi.nlm.nih.gov/pubmed/34580585 http://dx.doi.org/10.3389/fimmu.2021.737245 |
work_keys_str_mv | AT yanezdianac systemicpharmacologicalsmoothenedinhibitionreduceslungtcellinfiltrationandamelioratesth2inflammationinamousemodelofallergicairwaydisease AT papaioannoueleftheria systemicpharmacologicalsmoothenedinhibitionreduceslungtcellinfiltrationandamelioratesth2inflammationinamousemodelofallergicairwaydisease AT chawdamiram systemicpharmacologicalsmoothenedinhibitionreduceslungtcellinfiltrationandamelioratesth2inflammationinamousemodelofallergicairwaydisease AT rowelljasmine systemicpharmacologicalsmoothenedinhibitionreduceslungtcellinfiltrationandamelioratesth2inflammationinamousemodelofallergicairwaydisease AT rosssusan systemicpharmacologicalsmoothenedinhibitionreduceslungtcellinfiltrationandamelioratesth2inflammationinamousemodelofallergicairwaydisease AT lauchingin systemicpharmacologicalsmoothenedinhibitionreduceslungtcellinfiltrationandamelioratesth2inflammationinamousemodelofallergicairwaydisease AT cromptontessa systemicpharmacologicalsmoothenedinhibitionreduceslungtcellinfiltrationandamelioratesth2inflammationinamousemodelofallergicairwaydisease |